The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index; 9 of the 28 sources its claims cite were checked for support.
Minding the gap between cortisol levels measured with second-generation assays and current diagnostic thresholds for the diagnosis of adrenal insufficiency: a single-center experience
Open accessAbstract
Purpose: The current cut-offs for the diagnosis of adrenal insufficiency (AI) have been established using outdated immunoassays. We compared the cortisol concentrations measured with Roche Cortisol I (R1), the newly available Roche Cortisol II (R2), and liquid chromatography tandem mass spectrometry (LC-MS/MS), the gold standard procedure to measure steroids in patients undergoing the corticotropin (ACTH) test. Methods: We enrolled 30 patients (age 47 ± 21 years) referred to undergo the ACTH test (1 or 250 μg). Cortisol was measured at 0, 30, and 60 min after stimulation with R1, R2, and LC-MS/MS. AI was diagnosed for R1-stimulated peak cortisol concentrations < 500 nmol/L. Results: Mean cortisol concentrations measured with R2 and LC-MS/MS were comparable, while mean cortisol concentrations measured by R1 were higher than those of both R2 and LC-MS/MS (respectively, basal 411 ± 177, 287 ± 119, and 295 ± 119 nmol/L; at 30 min, 704 ± 204, 480 ± 132, and 500 ± 132 nmol/L; at 60 min, 737 ± 301, 502 ± 196, and 519 ± 201 nmol/L, p ≤ 0.01 for R1 vs. both R2 and LC-MS/MS at each point). Considering the 500 nmol/L cortisol peak cut-off, AI was diagnosed in 5/30 patients using R1 and in 12/30 using R2 (+ 140%). Based on the correlation between R1 and R2, the threshold of 500 nmol/L became 351 nmol/L (12.7 μg/dL) when cortisol was measured with R2, and 368 nmol/L (13.3 μg/dL) with LC-MS/MS. Conclusions: The use of more specific cortisol assays results in lower cortisol concentrations. This could lead to misdiagnosis and overtreatment when assessing AI with the ACTH test if a different cut-off for cortisol peak is not adopted.
Overview
CoChat Summary
TL;DR
In 30 patients undergoing ACTH testing, cortisol measured with the second-generation Roche Cortisol II (R2) assay was comparable to LC-MS/MS, while the first-generation Roche Cortisol I (R1) assay gave substantially higher values. Applying the traditional 500 nmol/L peak cut-off to R2 increased adrenal insufficiency diagnoses from 5/30 to 12/30, indicating that assay-specific lower thresholds are needed.
Key findings
- Mean cortisol concentrations by R1, R2, and LC-MS/MS were, respectively, 411 ± 177, 287 ± 119, and 295 ± 119 nmol/L basally; 704 ± 204, 480 ± 132, and 500 ± 132 nmol/L at 30 min; and 737 ± 301, 502 ± 196, and 519 ± 201 nmol/L at 60 min, with R1 significantly higher than both R2 and LC-MS/MS at each time point (p < 0.001).
- Using the 500 nmol/L peak cortisol cut-off, AI was diagnosed in 5/30 patients with R1 and 12/30 with R2, a +140% increase.
- Based on R1–R2 correlation, the 500 nmol/L R1 threshold corresponded to 351 nmol/L (12.7 μg/dL) for R2 and 368 nmol/L (13.3 μg/dL) for LC-MS/MS.
- Passing-Bablok analysis showed R1 vs. R2 slope 1.54 and intercept −41.00; R1 vs. LC-MS/MS slope 1.52 and intercept −60.07; R2 vs. LC-MS/MS slope 0.99 and intercept −11.39. Bland-Altman showed R1 values were approximately 36% higher than R2 and 32% higher than LC-MS/MS, while R2 was approximately 4% lower than LC-MS/MS.
Methods
- Single-center study of 30 consecutive adults (age 47 ± 21 years) referred for suspected adrenal insufficiency; 15 underwent standard-dose ACTH test (250 μg) and 15 underwent low-dose ACTH test (1 μg).
- Cortisol was measured at 0, 30, and 60 min after stimulation with R1, R2, and LC-MS/MS; AI was diagnosed when R1-stimulated peak cortisol was < 500 nmol/L.
- Main analysis used Passing-Bablok regression, Cusum test, Spearman correlation, and Bland-Altman plots; the authors calculated R2 and LC-MS/MS cortisol concentrations corresponding to an R1 cortisol concentration of 500 nmol/L.
Limitations
- The paper states the main limitations were lack of a control group for both SDCT and LDCT, low number of included patients, and use of two different tests (SDCT and LDCT), which could have introduced bias.
- The text also notes that no studies have evaluated cortisol response after LDCT by R2 and LC-MS/MS in healthy subjects, and that new clinically derived thresholds are not yet available.
- Evident from the text: this is a single-center experience with no clinical outcome validation of the proposed lower cut-offs.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
3 Valid · 1 Not valid · 7 Not checked · 24 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Indeed, it is well known that LC-MS/MS and GC-MS/MS, the gold standard procedures for steroid measurement due to their lower cross-reactivity with other steroids, provide lower cortisol concentrations than older assays [14, 15, 18].”
§ Minding the gap between cortisol levels measured with second-generation assays and current diagnostic thresholds for the diagnosis of adrenal insufficiency: a single-center experience > Discussion
What the sources say
- Partly supportedcites [14] Vogeser M, Kratzsch J, Ju Bae Y, Bruegel M, Ceglarek U, Fiers T, Gaudl A, Kurka H, Milczynski C, Prat Knoll C, Suhr AC, Teupser D, Zahn I, Ostlund RE (2017) Multicenter performance evaluation of a second generation cortisol assay. Clin Chem Lab Med 55(6):826–835 sourceExperimental — accuracy not yet measured
Our copy of Vogeser et al. 2017 supports the framing half of the sentence: the Introduction (p. 2) and Discussion (p. 8) describe GC-MS/MS as the traditional reference method and LC-MS/MS as 'the current gold standard for cortisol measurement', with immunoassay specificity limited by cross-reactivity from cortisone, prednisolone and dexamethasone. It does not state that MS methods yield lower cortisol concentrations than older assays: the study compares the second-generation Cortisol II assay, not older assays, against in-house LC-MS/MS (Method comparison, p. 4). The closest data are Method comparisons (pp. 5-6), where Cortisol II reads higher than LC-MS/MS (serum slope 1.02, mean bias 14.55 nmol/L; saliva slope 1.134, mean bias 2.56 nmol/L) and lower than the first-generation assay (serum slope 0.76, mean bias -91.11 nmol/L) — an indirect chain the paper never draws out as a claim about older assays versus MS. (LLM, conf=0.65)
- Not checked yetcites [15] Ueland G, Methlie P, Øksnes M, Thordarson HB, Sagen J, Kellmann R, Mellgren G, Ræder M, Dahlqvist P, Dahl SR, Thorsby PM, Løvås K, Husebye ES (2018) The short cosyntropin test revisited: new normal reference range using LC-MS/MS. J Clin Endocrinol Metab 103(4):1696–1703 source
- Not checked yetcites [18] Kline GA, Buse J, Krause RD (2017) Clinical implications for biochemical diagnostic thresholds of adrenal sufficiency using a highly specific cortisol immunoassay. Clin Biochem 50(9):475–480 source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Although morning serum cortisol concentrations are helpful to determine hypothalamic-pituitary-adrenal axis function, the evidence in the literature is as yet insufficient to support the use of basal cortisol concentrations alone in order to either rule out or confirm AI [1–5].”
§ Minding the gap between cortisol levels measured with second-generation assays and current diagnostic thresholds for the diagnosis of adrenal insufficiency: a single-center experience > Introduction
What the sources say
- Partly supportedcites [1] Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, Husebye ES, Merke DP, Murad MH, Stratakis CA, Torpy DJ (2016) Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 101:364–389 sourceExperimental — accuracy not yet measured
The Diagnosis of primary adrenal insufficiency section says low morning cortisol is ordinarily confirmed by stimulated cortisol and that ACTH is needed to make primary adrenal insufficiency highly likely. The Evidence section calls a low morning cortisol suggestive and says the threshold for ruling out adrenal insufficiency is controversial. These passages support the claim for primary adrenal insufficiency, but the guideline does not establish it for all forms of adrenal insufficiency or for hypothalamic-pituitary-adrenal axis function generally. (LLM, conf=0.84)
- Partly supportedcites [2] Husebye ES, Allolio B, Arlt W, Badenhoop K, Bensing S, Betterle C, Falorni A, Gan EH, Hulting AL, Kasperlik-Zaluska A, Kämpe O, Løvås K, Meyer G, Pearce SH (2014) Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. J Intern Med 275(2):104–115 sourceExperimental — accuracy not yet measured
The Conclusions (Table 1; page unavailable) recommend measuring serum cortisol together with plasma ACTH to diagnose primary adrenal insufficiency, with stimulation testing in equivocal cases. The diagnostic recommendations also note that some patients have cortisol within the normal range at diagnosis. This supports the point that cortisol alone may not settle the diagnosis, but the paper addresses primary adrenal insufficiency specifically, not all forms of AI, and does not make the cited sentence’s morning-specific statement about the sufficiency of the evidence. (LLM, conf=0.84)
- Partly supportedcites [3] Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R, Samuels MH (2016) Hormonal replacement in hypopituitarism in adults: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 101(11):3888–3921 sourceExperimental — accuracy not yet measured
The Central Adrenal Insufficiency section recommends morning cortisol as a first-line test and calls for a stimulation test when values are 3–15 mcg/dL. But it also says a value below 3 mcg/dL is indicative of AI and one above 15 mcg/dL likely excludes it. The claim is therefore supported for intermediate values, not for morning cortisol concentrations generally. (LLM, conf=0.88)
- Not checked yetcites [4] Schneider HJ, Aimaretti G, Kreitschmann-Andermahr I, Stalla GK, Ghigo E (2007) Hypopituitarism. Lancet 369(9571):1461–1470 source
- Partly supportedcites [5] Pofi R, Feliciano C, Sbardella E, Argese N, Woods CP, Grossman AB, Jafar-Mohammadi B, Gleeson H, Lenzi A, Isidori AM, Tomlinson JW (2018) The short Synacthen (corticotropin) test can be used to predict recovery of hypothalamo-pituitary-adrenal axis function. J Clin Endocrinol Metab 103(8):3050–3059 sourceExperimental — accuracy not yet measured
The Abstract (page not provided) says morning cortisol can help predict short Synacthen test outcomes, while the test’s 30-minute cortisol result is the standard for assessing adrenal reserve. This supports the distinction between a helpful basal measurement and a confirmatory test, but the paper does not establish the broader claim that morning cortisol alone is insufficient to either rule out or confirm AI. (LLM, conf=0.78)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and 368 nmol/L (13.3 μg/dL) with LC-MS/MS.”
- Also stated in: § Results · plain
“Similarly, applying the correlation between R1 and LC-MS/MS cortisol concentrations, we found that the cut-off for diagnosing AI would be 368 nmol/L (13.3 μg/dL) (Fig. 1b).”
- Also stated in: § Discussion · plain
“and 368 nmol/L (13.3 μg/dL) with LC-MS/MS.”
§ Minding the gap between cortisol levels measured with second-generation assays and current diagnostic thresholds for the diagnosis of adrenal insufficiency: a single-center experience > Abstract > Results
plainstates an associationn = 30- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Also stated in: § Results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The same response was obtained for R1 vs. LC-MS/MS, in which the Passing-Bablok intercept of the linear regression was − 60.07 (95% CI: − 98.60; − 24.53) and the slope was 1.52 (95% CI: 1.43; 1.62) (Table 2).”
- Also stated in: § Results · plain
“R1 vs. LC-MS/MS | y = − 60.07 + 1.52x | − 98.60; − 24.53 | 1.43–1.62 | N.S. deviation from linearity (p = 0.635) | 0.960 (p < 0.001)”
§ Minding the gap between cortisol levels measured with second-generation assays and current diagnostic thresholds for the diagnosis of adrenal insufficiency: a single-center experience > Results
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In our study, none of the patients undergoing SDCT was diagnosed as AI when measuring cortisol levels by R1 and using the traditional cut-off.”
§ Minding the gap between cortisol levels measured with second-generation assays and current diagnostic thresholds for the diagnosis of adrenal insufficiency: a single-center experience > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
19 more claims
Create a free account to see all 35 claims and to verify the 19 references still open.
- Probably not a substantial claim. 4
- It may state two separate claims as one. 8
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Serum cortisol concentrations measured with the newer assays when compared to those measured with the older ones are sharply lower by 20 up to 36%, according to different studies and assays [45,46,47].”
From ACTH Stimulation Test for the Diagnosis of Secondary Adrenal Insufficiency: Light and Shadow (2023) · cites this paper as [47]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Grassi et al also found lower cortisol cutoff values of 12.7 and 13.3 μg/dL using Elecsys II and LC-MS/MS assays, respectively [37].”
From New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays (2021) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“based on three replicate and three analytical sessions (N = 12)”
§ Minding the gap between cortisol levels measured with second-generation assays and current diagnostic thresholds for the diagnosis of adrenal insufficiency: a single-center experience > Material and methods > Assays
Reported 12 · recomputed 9
Citations
Cites
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965
(1965) · The Lancet · doi:10.1016/s0140-6736(65)91037-8 · Cited by 16,856
Bornstein, S. R., Allolio, B., Arlt, W., Barthel, A., Don-Wauchope, A., Hammer, G. D., Husebye, E. S., Merke, D. P., Murad, M. H., Stratakis, C. A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1710 · Cited by 1,769
Passing, H., & Bablok, W. (1983) · cclm · doi:10.1515/cclm.1983.21.11.709 · Cited by 1,513 · cited 1×
“R1, R2, and LC-MS/MS cortisol concentrations were compared with a nonparametric Passing and Bablok regression analysis, a Cusum test, and Spearman correlation coefficients [19].”
MethodHormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
Arlt, W., & Allolio, B. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13492-7 · Cited by 819
Husebye, E. S., Allolio, B., Arlt, W., Badenhoop, K., Bensing, S., Betterle, C., Falorni, A., Gan, E. H., Hulting, A. ‐., Kasperlik‐Zaluska, A., et al. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12162 · Cited by 403
Measuring cortisol in serum, urine and saliva—Are our assays good enough?
El-Farhan, N., Rees, D. A., & Evans, C. (2017) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563216687335 · Cited by 395
Corticotropin tests for hypothalamic-pituitary- adrenal insufficiency: a metaanalysis
Kazlauskaite, R., Evans, A. T., Villabona, C. V., Abdu, T. A. M., Ambrosi, B., Atkinson, A. B., Choi, C. H., Clayton, R. N., Courtney, C. H., Gonc, E. N., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0710 · Cited by 385
Schneider, H. J., Aimaretti, G., Kreitschmann-Andermahr, I., Stalla, G.-K., & Ghigo, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60673-4 · Cited by 336
Cited by
Javorsky, B. R., Raff, H., Carroll, T. B., Algeciras-Schimnich, A., Singh, R. J., Colón-Franco, J. M., & Findling, J. W. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab022 · Cited by 171
“3 μg/dL using Elecsys II and LC-MS/MS assays, respectively [37].”
MethodBrown, J. M., Auchus, R. J., Honzel, B., Luther, J. M., Yozamp, N. S., & Vaidya, A. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac049 · Cited by 46
“Similar changes to clinical interpretations of testosterone [52] and cortisol [53, 54] values, due to the use of LC-MS/MS or more modern immunoassays, have already been recognized and recommended in the routine evaluation of hypogonadism and adrenal insufficiency, respectively.”
Circadian Biomarkers in Humans: Methodological Insights into the Detection of Melatonin and Cortisol
Skubic, C., Zevnik, U., Nahtigal, K., Dolenc‐Grošelj, L., & Rozman, D. (2025) · Biomolecules · doi:10.3390/biom15071006 · Cited by 42
“[105] ECLIA (Cortisol I and II) vs. LC–MS/MS on stimulated serum cortisol.”
Perioperative evaluation and management of patients on glucocorticoids
Chen Cardenas, S. M., Santhanam, P., Morris-Wiseman, L., Salvatori, R., & Hamrahian, A. H. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac185 · Cited by 31
Zha, L., Li, J., Krishnan, S. M., Brennan, M. R., Zhang, Y. V., Povse, P., Kerlin, R., Shively, K., Oleksik, F., Williams, J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.04.003 · Cited by 34
Metadata
- Authors
- Grassi, G., Morelli, V., Ceriotti, F., Polledri, E., Fustinoni, S., D’Agostino, S., Mantovani, G., Chiodini, I., & Arosio, M.
- Affiliations
- University of Milan (IT)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- Corresponding author
- Grassi, G.
- Venue
- Hormones
- Published
- 2020-03-28
- Volume
- 19
- Issue
- 3
- Pages
- 425-431
- ISSN
- 1109-3099 (ISSN-L)
- 2520-8721
- PMC
- PMC7426310
- OpenAlex
- W3014072263
- Semantic Scholar
- 0074dba1f843442716eac53a8ba9765b2f570a0d
- Cited by
- 46
- References
- 25
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 6 · 2023: 5 · 2022: 9 · 2021: 8
- FWCI
- 4.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- HORMONES (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, cc-by)
- Funders
- Ricerca Corrente Funds from the Italian Ministry of Health to Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (NA)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- adrenal insufficiency, ACTH stimulation test, diagnostic thresholds, liquid chromatography-tandem mass spectrometry, assay comparison, misdiagnosis, overtreatment, Cushing's disease
- MeSH terms
- Adrenal Insufficiency, Adrenocorticotropic Hormone, Adult, Aged, Chromatography, Liquid, Female, Humans, Hydrocortisone, Immunoassay, Male, Middle Aged, Tandem Mass Spectrometry, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Minding the gap between cortisol levels measured with second-generation assays and current diagnostic thresholds for the diagnosis of adrenal insufficiency: a single-center experience. https://app.cochat.ai/papers/10.1007/s42000-020-00185-y
- The paper
- Grassi, G., Morelli, V., Ceriotti, F., Polledri, E., Fustinoni, S., D’Agostino, S., Mantovani, G., Chiodini, I., & Arosio, M. (2020). Minding the gap between cortisol levels measured with second-generation assays and current diagnostic thresholds for the diagnosis of adrenal insufficiency: a single-center experience. Hormones. https://doi.org/10.1007/s42000-020-00185-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.